$10.29 0.0 0.0%
Last Trade - 06/12/19
Market Cap | £317.0m |
Enterprise Value | £316.0m |
Revenue | £n/a |
Position in Universe | 3111th / 6412 |
July 30 (Reuters) - New Frontier Corp NFC.N : * NEW FRONTIER CORPORATION TO ACQUIRE UNITED FAMILY HEALTHCARE * NEW FRONTIER CORP - WITH ANTICIPATED INITIAL ENTERPRISE VALUE OF $1,440 MILLION NEW COMPANY WILL OPERATE UNDER NAME OF NEW FRONTIER HEALTH CORPORATION * NEW FRONTIER CORP - FOLLOWING CLOSE OF TRANSACTION ANTONY LEUNG WILL BECOME CHAIRMAN OF COMPANY'S BOARD OF DIRECTORS * NEW FRONTIER CORP - NEW COMPANY WILL OPERATE UNDER NAME OF NEW FRONTIER HEALTH CORPORATION * NEW FRONTIER CORP - FOLLOWING CLOSE OF TRANSACTION QIYU CHEN WILL BE CO-CHAIRMAN OF COMPANY'S BOARD OF DIRECTORS * NEW FRONTIER CORP - FOLLOWING CLOSE OF TRANSACTION ROBERTA LIPSON WILL BE CEO OF NFH * NEW FRONTIER CORP - TO FUND DEAL, OBTAINED ADDITIONAL $711 MILLION IN EQUITY COMMITMENTS (AT $10.00 PER SHARE) FROM A GROUP OF INVESTORS * NEW FRONTIER CORP - UPON CLOSING OF TRANSACTION, COMPANY IS EXPECTED TO TRADE ON NEW YORK STOCK EXCHANGE UNDER SYMBOL "NFH" * NEW FRONTIER - UPON CLOSING OF DEAL, CO EXPECTED TO TRADE ON NEW YORK STOCK EXCHANGE UNDER SYMBOL "NFH" * NEW FRONTIER CORP - ALSO EXPECTS TO FUND ACQUISITION OF UFH USING ABOUT $478 MILLION OF CASH PROCEEDS FROM NFC'S INITIAL PUBLIC OFFERING * NEW FRONTIER CORP - FOSUN PHARMA WILL REMAIN AS AN IMPORTANT LONG-TERM STRATEGIC PARTNER * NEW FRONTIER - EXISTING MANAGEMENT OF UFH & FOSUN PHARMA, TOGETHER EXPECTED TO OWN AGGREGATE OF ABOUT 12% OF NFH AT CLOSING Source text for Eikon: ID:nGNX2M9JBP Further company coverage: NFC.N ((Reuters.Briefs@thomsonreuters.com;))